Responses
Clinical and epidemiological research
Extended report
Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
Compose a Response to This Article
Other responses
No responses have been published for this article.